SELECT PUBLICATIONS
Cassidy J et al. XELOX (capecitabine plus oxaliplatin): Active first-line therapy for
patients with metastatic colorectal cancer. J Clin Oncol 2004;22(11):2084–91. Abstract
Kelly H, Goldberg RM. Systemic therapy for metastatic colorectal cancer: Current
options, current evidence. J Clin Oncol 2005;23(20):4553-60. Abstract
Meyerhardt JA, Mayer RJ. Systemic therapy for colorectal cancer. N Engl J Med
2005;352(5):476-87. No abstract available
Saltz LB et al. Randomized phase II trial of cetuximab/bevacizumab/irinotecan (CBI)
versus cetuximab/bevacizumab (CB) in irinotecan-refractory colorectal cancer.
J Clin Oncol 2005;23(16s):248. Abstract 3508
Twelves C et al. Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J
Med 2005;352(26):2696-704. Abstract
